Endurant Capital Management’s Cano Health, Inc. CANO Stock Holding History

Endurant Capital Management’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,109	Closed	-$1.83M	–	77
2022 Q3	$1.83M	Buy	+2,109	New	+$1.32M	0.6%	33
2021 Q3	–	Sell	-620	Closed	-$750K	–	69
2021 Q2	$750K	Buy	+620	New	+$836K	0.21%	55

Other funds holding CANO

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Endurant Capital Management's CANO Position: Q4 2022 in Review

Endurant Capital Management sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 2,109 shares — an estimated $1.83M sold.

Endurant Capital Management first reported a position in CANO in Q2 2021 and held it in 2 quarters. The position peaked at $1.83M in Q3 2022. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

Endurant Capital Management reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
Endurant Capital Management sold 2,109 Cano Health, Inc. shares in Q4 2022, an estimated $1.83M.
Endurant Capital Management first reported a position in Cano Health, Inc. in Q2 2021 and held it in 2 quarters.
Endurant Capital Management's Cano Health, Inc. position peaked at $1.83M in Q3 2022.
186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Endurant Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.